Skip to main content
. 2019 Jan-Mar;29(1):40–46. doi: 10.4103/ijri.IJRI_454_18

Table 1.

Patient demographics

Parameters Patient numbers (n=28)
Sex (M/F) 22/6
Age (mean, range) 55.6 years (35-72)
Tumor type (n %)
 Cholangiocarcinoma 14
 Hepatocellular carcinoma 5
 Gall bladder carcinoma 9
Underlying liver damage/Systemic disease
 Cirrhosis 19
 Neoadjuvant chemotherapy 5
 Diabetes mellitus 6
PVE approach
 Ipsilateral PVE 6
 Contralateral PVE 22